R Shapiro
Overview
Explore the profile of R Shapiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
642
Citations
6823
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erchick D, Hazel E, Katz J, Lee A, Diaz M, Wu L, et al.
BJOG
. 2023 May;
PMID: 37156239
Objective: To examine prevalence of novel newborn types among 541 285 live births in 23 countries from 2000 to 2021. Design: Descriptive multi-country secondary data analysis. Setting: Subnational, population-based birth...
2.
Davidovich E, Polak D, Brand H, Shapira J, Shapiro R
Eur Arch Paediatr Dent
. 2020 Nov;
22(2):257-263.
PMID: 33135122
Purpose: To investigate associations between levels of blood parameters used to monitor liver-transplanted children with their salivary levels, and compare the salivary parameters of transplant recipients with those of healthy...
3.
Riedl M, Aygoren-Pursun E, Baker J, Farkas H, Anderson J, Bernstein J, et al.
Allergy
. 2018 Apr;
73(9):1871-1880.
PMID: 29688579
Background: Effective inhibition of plasma kallikrein may have significant benefits for patients with hereditary angioedema due to deficiency of C1 inhibitor (C1-INH-HAE) by reducing the frequency of angioedema attacks. Avoralstat...
4.
The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis
Axelrod D, Lentine K, Schnitzler M, Luo X, Xiao H, Orandi B, et al.
Am J Transplant
. 2017 Jun;
17(12):3123-3130.
PMID: 28613436
Incompatible living donor kidney transplantation (ILDKT) has been established as an effective option for end-stage renal disease patients with willing but HLA-incompatible living donors, reducing mortality and improving quality of...
5.
Kirk A, Malchesky P, Shapiro R, Webber S, Hirsch H, Marty F, et al.
Am J Transplant
. 2016 Aug;
16(9):2505-7.
PMID: 27529615
No abstract available.
6.
Ebcioglu Z, Liu C, Shapiro R, Rana M, Salem F, Florman S, et al.
Am J Transplant
. 2016 Jun;
16(11):3278-3281.
PMID: 27328903
We report an HIV-positive renal transplant recipient with delayed graft function who was converted from tacrolimus to belatacept in an attempt to improve renal function. The patient had kidney biopsies...
7.
Lahat E, Nevler A, Batumsky M, Shapiro R, Zmora O, Gutman M
Tech Coloproctol
. 2016 Jan;
20(3):163-9.
PMID: 26757901
Background: Splenic injury following colonoscopy is a rare yet life-threatening complication. These injuries are often associated with delayed diagnosis and may require invasive intervention. We sought to study the emergent...
8.
Duquesnoy R, Gebel H, Woodle E, Nickerson P, Baxter-Lowe L, Bray R, et al.
Am J Transplant
. 2015 Jul;
15(10):2780-1.
PMID: 26177785
No abstract available.
9.
Duquesnoy R, Kamoun M, Baxter-Lowe L, Woodle E, Bray R, Claas F, et al.
Am J Transplant
. 2015 Mar;
15(4):923-30.
PMID: 25778447
Defining HLA mismatch acceptability of organ transplant donors for sensitized recipients has traditionally been based on serologically defined HLA antigens. Now, however, it is well accepted that HLA antibodies specifically...
10.
Randhawa P, Pastrana D, Zeng G, Huang Y, Shapiro R, Sood P, et al.
Am J Transplant
. 2015 Mar;
15(4):1014-20.
PMID: 25736704
Neutralizing antibodies (NAbs) form the basis of immunotherapeutic strategies against many important human viral infections. Accordingly, we studied the prevalence, titer, genotype-specificity, and mechanism of action of anti-polyomavirus BK (BKV)...